Member Info for MisterPositive

Montmuzard.

Thanks for sharing. Very interesting numbers.

Bio-tech stocks can have phenomenal Upside.

With almost 50% shares held by significant shareholders, free float is tiny exacerbating the move Upwards even more on strong momentum.

52 week high here is 5.52p which I think will be taken out.

8p at the upper range is very much possible depending on strong momentum that is building now. Very difficult to second guess RNS timing like the one today which came around 11 am.

They just need to cancel this stupid Zeus deal before any updates to get a meaningful rise.

Today's Holdings RNS totally changed the equation here, right at time when FDA approval is due any time now.

Best to sit tight...or accumulate if not in already.

Let's see which RNS lands here first.

Again NT for even £250 worth on Barclays 😁

Bagpuss

As per Takeover rules, any "Potential Bidder" needs to see full list of shareholders, especially the "Significant shareholders". Their full name, Nature of Control (direct & indirect control) with their Holdings and Voting rights %.

We might have received an initial friendly Takeover approach which the BOD are not obliged to disclose. However if this goes up +50% or 70% tomorrow, then the BOD might have to issue an RNS with the usual wording....initial Takeover approach significantly undervalues the company etc etc.

Speculation but the most logical explanation for today's Holding RNS was to make it public, especially to any "Potential Bidder".

IMHO.

Today's Holding RNS almost 14%

Philip Chesterfield 9.45%

Maven Capital partners 7%

First Equity Ltd 4%

Few others just below 3%

Not many shares about.

No wonder keeps going to NT to buy for just £200?

This got to over +4p just on NEW YORK STATE approval.

Where will it go on FDA approval for whole of USA

Volume almost 5 times daily average so far

Very interesting timing for Holdings RNS

With FDA approval any time.

Brace for thrilling days ahead.

NT to buy for last few mins Barclays

Defo looks like some sort of "Initial Approach" received by BOD.

BOD needs to know FULL LIST of shareholders with their respective % HOLDINGS before replying to incoming Takeover Offer.

They need to know Voting rights %

Today's Holding RNS relates to 13.76% at 6 Feb.

By now position could have increased to 20% who knows. Another 10% and they go to 30%.

OFFER time. What price though ?

52 week high 5.5p

After FDA approval could be DOUBLE that.

Something definitely has triggered that Holdings RNS now just before FDA approval.

Normally you are asked to reveal Holdings before any TAKEOVER approach is made public by the Board of directors.

Not many folks seen the intra-day Holdings RNS

Wonder if the same investor has added further to the already +74m shares ?

Going for may be nice round +100m !!

Blimey....74m shares....wow

This dropped from 1.90 pence in Jan 2026 when GENI raised £4.7m

Would expect it back @ 1.90 as first stop

Time to accumulate here. Never thought would be able to Buy below 4p...what a gift 🎁

With so much news to come here, this should be back at +4p and higher.

KEN got ahead of itself touching £39m MCap. Should be other way round.

ALTONA should be close to £50m MCap.

We do NOT need funds now. We already raised over +£1m just from the warrants so far.

Plus +$1.875m.USTDA grant funds.

Cedric was planning ahead for later in the year.

Have requested Zeus deal to be canceled.

Could see awaited Hole 16 results this week.

FDA approval takes Genincode WORLDWIDE, not just whole of USA.

Updates also due from both UK and Europe. Genincode been making strong progress all around. Results will provide more details on progress made to date.

Equity research analysts will also focus on the "Future Outlook" for Genincide. Could see price targets revised Upwards from current 7.50-8p